Alkermes plc. (ALKS) stock

ALKSNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 5/30213% above fair value

$46.98−0.91 (-1.90%)

Close on Nov 12, 2026Market cap $7.88BP/E 123.6Yield –

Alkermes price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Alkermes's price to book ratio was 4.4× on Nov 11, 2026, against 2.8× a year earlier. Over the last 5 years it ranged from 2.7× to 5.2×, with a median of 3.7×.

Price to Book Ratio at the end of each year

Period	Period end	Value	Change (pts)
2026	Nov 11, 2026	4.4×	+1.8
2025	Dec 31, 2025	2.7×	−0.9
2024	Dec 31, 2024	3.6×	+0.2
2023	Dec 29, 2023	3.4×	−0.7
2022	Dec 30, 2022	4.1×	+0.7
2021	Dec 31, 2021	3.4×	+0.5
2020	Dec 31, 2020	2.9×	−0.1
2019	Dec 31, 2019	3.0×	−1.0
2018	Dec 31, 2018	4.0×	−3.1
2017	Dec 29, 2017	7.1×	+0.1
2016	Dec 30, 2016	7.0×	−1.7
2015	Dec 31, 2015	8.7×	+0.5
2014	Dec 31, 2014	8.2×	+2.5
2013	Dec 31, 2013	5.7×	+3.0
2012	Dec 31, 2012	2.8×	+0.3
2011	Dec 30, 2011	2.5×	−0.3
2010	Dec 31, 2010	2.8×	–